NextPlat Corp (NXPL): NXPL has been losing value since it hit...

CaptHowdy · 2025-03-29T02:49:02.5770000Z

NXPL has been losing value since it hit $1.50 last year. Certainly the recent market conditions don't help, however we can all agree that Fernandez is not a very effective nor successful CEO. His leadership of NXPL is the reason why RXMD tanked under his command and the reason why NXPL never gained any momentum when it wasn't associated with RXMD. Bottom line.....he's not qualified to be running a NASDAQ listed company until proven otherwise.

Play Episode

4min

Proactive - Interviews for investors

Reconnaissance Energy Africa provides drilling update on Prospect I in Namibia

Reconnaissance Energy Africa CEO Brian Reinsborough joined Steve Darling from Proactive to share a drilling update on Prospect I, located onshore Namibia within Petroleum Exploration Licence 073. Prospect I represents the company’s largest exploration target to date. It is estimated to hold approximately 365 million barrels of unrisked and 32 million barrels of risked prospective light to medium oil resources, or alternatively, 1.9 trillion cubic feet of unrisked and 140 billion cubic feet of risked prospective natural gas resources, based on a 100% working interest. Reinsborough reported that pre-construction activities are progressing on schedule and that pre-drill evaluations have been successfully completed. Drilling is planned to reach a target depth of 3,800 metres, with the flexibility to drill deeper depending on subsurface conditions—similar to the company’s approach with the Naingopo exploration well. The Otavi geological section is anticipated to range between 1,500 and 1,800 metres in thickness, depending on total drilling depth. Insights gained from the Naingopo well have significantly enhanced ReconAfrica’s understanding of the Damara Fold Belt, particularly regarding time-depth migration and structural interpretation of the Mulden and Otavi formations. This same reservoir zone at Naingopo exhibited more than 50 metres of reservoir-quality carbonates and oil shows, underscoring its potential. These developments mark an important step in advancing ReconAfrica’s exploration strategy in one of Africa’s most promising onshore hydrocarbon basins. #proactiveinvestors #reconnaissanceenergyafricaltd #tsxv #reco #otcqx #recaf #NamibiaOil #ProspectI #OilExploration #EnergyUpdate #OnshoreDrilling #OilAndGasNews #AfricanEnergy #OilDiscovery #EnergyInvesting

Proactive - Interviews for investors

North Bay Resources announces first gold concentrate sale from Fran Gold Project

North Bay Resources CEO Jared Lazerson joined Steve Darling from Proactive to share news of the company’s first successful gold concentrate sale from a test shipment processed at the Bishop Gold Mill, using ore from the Fran Gold Project. Lazerson confirmed that final acceptance and settlement have been completed, with all refinery requirements met, and assay comparisons for gold, silver, and moisture content agreed upon. The test concentrate represents approximately 10 tons of gross ore, processed through the gravity-only circuit. Lazerson noted this marks an important milestone in the early phase of operations. The flotation circuit, which is expected to significantly enhance recovery rates, is set to come online this month. The company currently has another test shipment in process and has completed a third concentrate shipment, further validating operational momentum. The most recent sale netted approximately $400 per ton, based solely on gravity recovery. However, with further optimization and the integration of the flotation circuit, recoveries are projected to double, potentially reaching over 90% total recovery. This would raise the value per ton to around $800, significantly improving project economics. North Bay Resources currently has 75 tons of ore stockpiled at the Bishop Gold Mill, which will be processed as part of continued optimization and ramp-up. Additionally, there are approximately 5,000 tons of ore stockpiled at the project site, positioning the company for a steady flow of future shipments as operations scale. The CEO also discussed the reinterpretation of 15 years of historical drilling data—104 holes covering 18,000 metres—which has revealed the potential for a bulk tonnage deposit. This reinterpretation aligns with nearby major low-grade, high-volume gold projects like Mount Milligan and Blackwater. #proactiveinvestors #northbayresourcesinc #otc #nbri #PlatinumConcentrate #NorthBayResources #MiningNews #CaliforniaGold #JaredLazerson #G

Proactive - Interviews for investors

Ananda Develops U.S. presence as lead drug advances to Phase 1 clinical study

Ananda Pharma CEO Melissa Sturgess joined Steve Darling from Proactive to announce the company’s shares have begun trading on the OTCQB market in the United States, a strategic move that expands Ananda’s visibility and access to U.S. investors. The UK-based biopharmaceutical company is focused on developing regulatory-approved cannabinoid medicines for complex and chronic medical conditions. Sturgess emphasized the significance of entering the U.S. market, not only from a capital markets perspective but also as a key future territory for Ananda’s clinical and commercial ambitions. She also highlighted recent progress in the company’s clinical development pipeline, particularly around its lead investigational drug candidate, MRX1. Ananda recently received approval from the Alfred Hospital Human Research Ethics Committee in Australia to initiate a Phase 1 pharmacokinetic study of MRX1. The study will evaluate the safety, tolerability, and pharmacokinetics of two dose levels of the CBD-based drug in a cohort of 20 healthy adult volunteers—10 biological males and 10 biological females—to address known sex differences in CBD metabolism. MRX1 is a high-purity, pharmaceutical-grade cannabidiol (CBD) formulation developed under rigorous quality standards to ensure consistency, safety, and clinical reliability. It is intended for the treatment of chronic inflammatory pain conditions, where current treatment options often fall short in efficacy or come with undesirable side effects. Sturgess noted that this ethics approval marks a critical milestone in the company’s journey toward regulatory approval and commercial readiness. The trial is expected to generate key safety and dosing data to support future Phase 2 studies targeting patients with unmet needs in chronic pain management. #proactiveinvestors #aqse #ana #cbd #otcqb #MRX1 #CBDDrugDevelopment #CannabinoidTherapy #ClinicalTrials #FDAApproval #PharmaNews #BiotechStocks #OTCQB #GWPharma #CBDMedicine #ChronicPainTreat

Proactive - Interviews for investors

European Green Transition co-founder Cathal Friel outlines growth strategy as he takes chair

European Green Transition PLC (AIM:EGT) founder and non-executive chairman Cathal Friel talked with Proactive's Stephen Gunnion about his formal move into the non-executive chairman role and the company’s strategy going forward. Friel shared how European Green Transition (EGT) aims to build value by acquiring distressed yet revenue-generating assets, a model he has successfully applied with previous companies such as Amryt Pharma and hVIVO. “Our model going forward is to acquire low-priced, distressed, good value assets, bolt them together,” he said, emphasising the need for revenue-generating components or the capacity to make acquisitions profitable from day one. He reflected on EGT’s IPO in April 2024 and his transition from other responsibilities, including his long tenure with hVIVO. With that chapter closed, he now brings more focus to EGT’s growth. Friel confirmed that the company still holds the majority of the £6.5 million raised, having only used a small portion on its rare earth asset in Sweden. Monetising that asset remains a priority. EGT's strategy continues to centre on small teams, tight cost control, and targeting multi-fold returns over a 24-month horizon. “I’ll be very careful of [the shareholders’] cash. It’s like mine,” Friel added. Visit Proactive’s YouTube channel for more interviews. Don’t forget to like this video, subscribe, and turn on notifications so you never miss an update. #CathalFriel #EuropeanGreenTransition #EGT #RareEarths #MergersAndAcquisitions #SmallCapInvesting #GreenEconomy #MiningInvestment #ShareholderValue #hVIVO #AmrytPharma #IPO

Followers	54
Posts	5353
Boards Moderated	0
Alias Born	11/11/2014

Volume:	106,841
Day Range:	0.43 - 0.498
Bid:	0.463
Ask:	0.49
Last Trade Time:	7:42:22 PM EDT
Total Trades:	266

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

NXPL Detailed Quote

Recent NXPL News

More NXPL News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent NXPL News

Go Ad-Free